HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vahid Asgary Selected Research

Vahid Asgary Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 09/2017
3Breast Neoplasms (Breast Cancer)
01/2020 - 09/2017
2Inflammation (Inflammations)
01/2021 - 01/2019
1Glomerulonephritis
01/2021
1Hematologic Neoplasms (Hematological Malignancy)
01/2020
1Hyperhomocysteinemia
08/2018
1Hematologic Diseases (Blood Diseases)
10/2016
1Rabies (Hydrophobia)
01/2016

Drug/Important Bio-Agent (IBA)

3SilverIBA
01/2020 - 01/2016
2Biological ProductsIBA
01/2022 - 09/2017
1Asparaginase (Elspar)FDA Link
01/2022
1EnzymesIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2021
1InflammasomesIBA
01/2021
1Immunotoxins (Immunotoxin)IBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1ExotoxinsIBA
01/2020
1Propidium (Propidium Iodide)IBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Annexin A5IBA
01/2020
1CaspasesIBA
01/2020
1Caspase 3 (Caspase-3)IBA
01/2020
1silver chlorideIBA
12/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019
1guluronic acidIBA
01/2019
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
08/2018
1Imatinib Mesylate (Gleevec)FDA Link
09/2017
17- iodo- 8- hydroxy- 3- methyl- 1- (4- azidophenyl)- 2,3,4,5- tetrahydro- 1H- 3- benzazepineIBA
09/2017
1AntibodiesIBA
10/2016
1VaccinesIBA
01/2016
1aluminum sulfate (alum)IBA
01/2016

Therapy/Procedure

2Therapeutics
01/2020 - 01/2020
1Renal Dialysis (Hemodialysis)
01/2021
1Immunotherapy
01/2020
1Aftercare (After-Treatment)
01/2020